Gemcitabine: Difference between revisions
Content deleted Content added
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Gemzar'''is the brand name of the antineoplastic drug which [[Eli Lilly and Company]] developed. |
'''Gemzar'''is the brand name of the antineoplastic drug which [[Eli Lilly and Company]] developed. |
||
Pharmacologic ingredient is '''Gemcitabine''' and this is [[Nucleoside]] which replaced the hydrogen of 2' grades of [[deoxyribose]] of [[deoxycytidine]] by [[fluoride]]. |
Pharmacologic ingredient is '''Gemcitabine''' and this is [[Nucleoside]] which replaced the hydrogen of 2' grades of [[deoxyribose]] of [[deoxycytidine]] by [[fluoride]]. |
||
* ''' chemistry name''':2'-Deoxy-2',2'-difluorocytidine monohydrochloride |
|||
*''' generic name''':[[Gemcitabine]][[Hydrochloride]] |
|||
*'''[[mol.]][[formula]]''':C9H11F2N3O4・HCl |
|||
*'''[[mol.]][[weight]]''':299.66 |
|||
*'''[[CAS]] No.'''122111-03-9 |
|||
*'''[[melting point]]''':287-292°C |
|||
*'''[[boiling point]]''':N/D |
|||
*'''[[pH]]''':3 |
|||
*'''Appearance''':White to off white solid |
|||
== Medical description == |
|||
Revision as of 05:00, 15 March 2005
Gemzaris the brand name of the antineoplastic drug which Eli Lilly and Company developed. Pharmacologic ingredient is Gemcitabine and this is Nucleoside which replaced the hydrogen of 2' grades of deoxyribose of deoxycytidine by fluoride.
- chemistry name:2'-Deoxy-2',2'-difluorocytidine monohydrochloride
- generic name:GemcitabineHydrochloride
- mol.formula:C9H11F2N3O4・HCl
- mol.weight:299.66
- CAS No.122111-03-9
- melting point:287-292°C
- boiling point:N/D
- pH:3
- Appearance:White to off white solid